RYTM
Rhythm Pharmaceuticals, Inc.
Stock
$92.83−0.58 (−0.62%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months |
|---|---|
| Revenue | $240M |
| Gross profit | $214M |
| Operating income | −$201M |
| Net income | −$205M |
| EPS | −$3.11 |
| Free cash flow | −$180M |
Rhythm Pharmaceuticals, Inc.
$92.83−0.58 (−0.62%)Close Oct 2, 2026
| Metric | Last 12 months |
|---|---|
| Revenue | $240M |
| Gross profit | $214M |
| Operating income | −$201M |
| Net income | −$205M |
| EPS | −$3.11 |
| Free cash flow | −$180M |